Neumora Therapeutics, Inc. Common Stock (NMRA)
Since Nov 01, 2023, Neumora Therapeutics, Inc. Common Stock (NMRA) has reported earnings 11 times. On average the shares move ±7.06% post-earnings, with a positive reaction 54.5% of the time. Its largest post-earnings gain was +5.08% (Aug 06, 2025) and its largest decline was -17.2% (Mar 30, 2026). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
11
Avg Abs. Movement
±7.06%
Positive %
54.5%
Negative %
45.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $2.37 | $2.37 | $1.94 | 121,057 | -16.38% | open_in_new |
| Mar 30, 2026 | ☀ PRE | $2.11 | $2.12 | $1.93 | 140,482 | -17.2% | open_in_new |
| Nov 06, 2025 | ☀ PRE | $2.38 | $2.75 | $2.56 | 56,472 | -2.48% | open_in_new |
| Aug 06, 2025 | ☽ POST | $1.61 | $1.61 | $1.57 | 30,747 | +5.08% | open_in_new |
| May 12, 2025 | ☽ POST | $0.71 | $0.76 | $0.68 | 22,043 | +0.35% | open_in_new |
| Mar 03, 2025 | ☀ PRE | $1.61 | $1.62 | $1.41 | 36,207 | -9.62% | open_in_new |
| Nov 12, 2024 | ☀ PRE | $12.68 | $12.72 | $11.31 | 86,051 | -17.2% | open_in_new |
| Aug 06, 2024 | ☀ PRE | $11.93 | $12.21 | $12.02 | 29,100 | +0.33% | open_in_new |
| May 07, 2024 | ☀ PRE | $9.36 | $9.89 | $9.82 | 12,202 | +4.8% | open_in_new |
| Mar 07, 2024 | ☀ PRE | $18.82 | $19.31 | $18.99 | 4,911 | +2.93% | open_in_new |
| Nov 01, 2023 | ☽ POST | $10.66 | $10.96 | $10.79 | 6,318 | +1.25% | open_in_new |
Earnings Count
11
Total earnings in dataset
Avg Abs. Movement
±7.06%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
7 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 8-K | 20260529 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
Frequently asked about NMRA earnings
When does Neumora Therapeutics, Inc. Common Stock report earnings next? expand_more
Neumora Therapeutics, Inc. Common Stock (NMRA)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NMRA stock move after earnings? expand_more
Over 11 reports, NMRA has moved an average of ±7.06% the session after earnings, closing higher 54.5% of the time.
What was NMRA's biggest post-earnings move? expand_more
NMRA's largest post-earnings gain on record was +5.08% on Aug 06, 2025, and its largest decline was -17.2% on Mar 30, 2026.
Where can I find Neumora Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Neumora Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right